Makes it impossible for prices to rise. Fusilev sales can only go in one direction. Down over time unless they reprice it to stave off TEVA which will result in a rev increse but drop in profit.
The Co. is cornered until other Sales reach 60% of the total ; (Now just 15%).
On an annualized basis revenue from sources other than Fusilev represent 36% (35.87% to be exact) of the total revenue, not 15%.
Revenue has become significantly more diversified during 2012.